Natural killer cells actively patrol peripheral lymph nodes forming stable conjugates to eliminate MHC-mismatched targets

被引:76
作者
Garrod, Kyrn R.
Wei, Sindy H.
Parkert, Ian
Cahalan, Michael D. [1 ]
机构
[1] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA
关键词
motility; two-photon microscopy;
D O I
10.1073/pnas.0702867104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Natural killer (INK) cells are known to reject MHC-mismatched targets within blood organs, yet their role in peripheral lymphoid tissue remains unresolved. Here we address the capacity of INK cells to migrate within lymph nodes (LN) using two-photon microscopy to characterize cell velocities and interaction dynamics within the native lymphoid-tissue environment. Adoptively transferred unmanipulated NK cells were highly motile (6-7 mu m/min) and capable of forming transient contacts with both syngeneic and allogeneic B cells. Stable conjugate interactions (lasting >5 min) formed preferentially with allogeneic cells, resulting in diminished motility and subsequent elimination of the target cell. In marked contrast to unmanipulated cells, NK cells purified by CD49b-positive selection exhibited only limited motility (2-3 mu m/min). This velocity impairment arose largely because CD49b cross-linking enhanced NK cell adhesion to collagen fibers within the node. Moreover, CD49b cross-linking prevented NK cells from reconstituting effector cytolytic function in vivo, inhibited target cell lysis in vitro, and augmented IFN-gamma responses to IL-2 activation in vitro. Taken together our data demonstrate that NK cells are a functionally important component of the LN microenvironment, and that cell motility and effector function are strongly modulated via CD49b manipulation.
引用
收藏
页码:12081 / 12086
页数:6
相关论文
共 30 条
[1]   CD107a as a functional marker for the identification of natural killer cell activity [J].
Alter, G ;
Malenfant, JM ;
Altfeld, M .
JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 294 (1-2) :15-22
[2]   Cutting edge:: The mouse NK cell-associated antigen recognized by DX5 moncoclonal antibody is CD49b (α2 integrin, very late antigen-2) [J].
Arase, H ;
Saito, T ;
Phillips, JH ;
Lanier, LL .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1141-1144
[3]   Natural killer cell behavior in lymph nodes revealed by static and real-time imaging [J].
Bajénoff, M ;
Breart, B ;
Huang, AYC ;
Qi, H ;
Cazareth, J ;
Braud, VM ;
Germain, RN ;
Glaichenhaus, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (03) :619-631
[4]   Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes [J].
Bousso, P ;
Robey, E .
NATURE IMMUNOLOGY, 2003, 4 (06) :579-585
[5]   Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment [J].
Chen, SH ;
Kawashima, H ;
Lowe, JB ;
Lanier, LL ;
Fukuda, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12) :1679-1689
[6]   Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-α production [J].
Fanning, Stacey L. ;
George, Thaddeus C. ;
Feng, Di ;
Feldman, Steven B. ;
Megjugorac, Nicholas J. ;
Izaguirre, Alexander G. ;
Fitzgerald-Bocarsly, Patricia .
JOURNAL OF IMMUNOLOGY, 2006, 177 (09) :5829-5839
[7]   Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs [J].
Ferlazzo, G ;
Pack, M ;
Thomas, D ;
Paludan, C ;
Schmid, D ;
Strowig, T ;
Bougras, G ;
Muller, WA ;
Moretta, L ;
Münz, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (47) :16606-16611
[8]   Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells [J].
Ferlazzo, G ;
Tsang, ML ;
Moretta, L ;
Melioli, G ;
Steinman, RM ;
Münz, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (03) :343-351
[9]   Dendritic cells directly trigger NK cell functions:: Cross-talk relevant in innate anti-tumor immune responses in vivo [J].
Fernandez, NC ;
Lozier, A ;
Flament, C ;
Ricciardi-Castagnoli, P ;
Bellet, D ;
Suter, M ;
Perricaudet, M ;
Tursz, T ;
Maraskovsky, E ;
Zitvogel, L .
NATURE MEDICINE, 1999, 5 (04) :405-411
[10]   A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells [J].
Freud, AG ;
Becknell, B ;
Roychowdhury, S ;
Mao, HC ;
Ferketich, AK ;
Nuovo, GJ ;
Hughes, TL ;
Marburger, TB ;
Sung, J ;
Baiocchi, RA ;
Guimond, M ;
Caligiuri, MA .
IMMUNITY, 2005, 22 (03) :295-304